FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

19969211000001100: Mestinon 60mg tablets (Lexon (UK) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 07-Mar 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
67216901000001116 Mestinon 60mg tablets (Lexon (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
67217001000001117 Mestinon 60mg tablets (Lexon (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Mestinon 60mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Mestinon 60mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Mestinon 60mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel Import - supplier (qualifier value) false Inferred relationship Existential restriction modifier
Mestinon 60mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Mestinon 60mg tablets (Lexon (UK) Ltd) Is a Product containing precisely pyridostigmine bromide 60 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Mestinon 60mg tablets (Lexon (UK) Ltd) Has active ingredient Pyridostigmine bromide false Inferred relationship Existential restriction modifier
Mestinon 60mg tablets (Lexon (UK) Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Mestinon 60mg tablets (Lexon (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Mestinon 60mg tablets (Lexon (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Mestinon 60mg tablets (Lexon (UK) Ltd) Has specific active ingredient Pyridostigmine bromide true Inferred relationship Existential restriction modifier
Mestinon 60mg tablets (Lexon (UK) Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Mestinon 60mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Pyridostigmine true Inferred relationship Existential restriction modifier
Mestinon 60mg tablets (Lexon (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Mestinon 60mg tablets (Lexon (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Mestinon 60mg tablets (Lexon (UK) Ltd) Is a Mestinon true Inferred relationship Existential restriction modifier
Mestinon 60mg tablets (Lexon (UK) Ltd) Has basis of strength substance Pyridostigmine true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Mestinon 60mg tablets (Lexon (UK) Ltd) 200 tablet Has AMP True Mestinon 60mg tablets (Lexon (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start